Form 4: Mind Medicine (MindMed) Inc. Chief Accounting Officer Receives 50,000 Restricted Stock Units

Carrie Liao, Chief Accounting Officer of Mind Medicine (MindMed) Inc., was granted 50,000 restricted stock units (RSUs) on March 12, 2025, which vest quarterly starting June 1, 2025.

Summary

• Carrie Liao, the Chief Accounting Officer of Mind Medicine (MindMed) Inc., filed a Form 4 on March 13, 2025, reporting a change in beneficial ownership.
• On March 12, 2025, Ms. Liao acquired 50,000 common shares in the form of restricted stock units (RSUs).
• These RSUs vest in 16 equal quarterly installments, commencing on June 1, 2025, contingent upon Ms. Liao's continuous service to the company.
• The reporting person directly owns 142,270 common shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management incentives with shareholder value. The sentiment is therefore moderately positive.

Positives

• The grant of RSUs to the Chief Accounting Officer aligns her interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person providing continuous service to the Issuer on each such vesting date.

Industry Context

Grants of restricted stock units are a common form of executive compensation in the pharmaceutical and biotechnology industries, aligning management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see the RSU grant as a sign of the company's commitment to its leadership team.

Key Dates